Activation of JNK signaling has been confirmed to render chemotherapy resistance in a variety of malignancies, including hepatocellular carcinoma [40], gastric cancer [41], and pancreatic cancer [42]. The gene discussed is MAPK8; the disease is familial pancreatic carcinoma.